Streamline your CLL CNV analysis and alleviate the burden of running multiple assays

At OGT, we understand the challenge of analyzing the wide variety of chromosomal abnormalities that are associated with CLL. Using multiple technologies to analyze single nucleotide variants (SNVs) and insertions/deletions (indels) up to large copy-number variations (CNVs), including trisomies can be time-consuming and costly.

In this webinar learn how the SureSeq™ CLL + CNV NGS Panel alleviates the burden of running multiple assays and streamlines your CLL research to deliver a comprehensive genomic profile for each CLL sample using a single NGS assay.

In addition, discover how OGT’s complimentary Interpret™ software helps you to deliver fast and accurate aberration analysis for your lab - so you get effortless translation of your data into meaningful results, every time.

SureSeq: For Research Use Only; Not for Diagnostic Procedures.